Henning, J.-W.; Brezden-Masley, C.; Gelmon, K.; Chia, S.; Shapera, S.; McInnis, M.; Rayson, D.; Asselah, J.
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective. Curr. Oncol. 2023, 30, 8019-8038.
https://doi.org/10.3390/curroncol30090582
AMA Style
Henning J-W, Brezden-Masley C, Gelmon K, Chia S, Shapera S, McInnis M, Rayson D, Asselah J.
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective. Current Oncology. 2023; 30(9):8019-8038.
https://doi.org/10.3390/curroncol30090582
Chicago/Turabian Style
Henning, Jan-Willem, Christine Brezden-Masley, Karen Gelmon, Stephen Chia, Shane Shapera, Micheal McInnis, Daniel Rayson, and Jamil Asselah.
2023. "Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective" Current Oncology 30, no. 9: 8019-8038.
https://doi.org/10.3390/curroncol30090582
APA Style
Henning, J.-W., Brezden-Masley, C., Gelmon, K., Chia, S., Shapera, S., McInnis, M., Rayson, D., & Asselah, J.
(2023). Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective. Current Oncology, 30(9), 8019-8038.
https://doi.org/10.3390/curroncol30090582
